What is the address of MEDICAL PROGRESS GROUP?

The registered office of MEDICAL PROGRESS GROUP is located at Gustave Demanetstraat 87, 1020 Brussel.

Is MEDICAL PROGRESS GROUP still active?

Yes. According to the CBE (28 September 2026) MEDICAL PROGRESS GROUP is active, legal situation “Normale toestand”, started on 27 March 1992.

Is MEDICAL PROGRESS GROUP registered on Peppol?

No, MEDICAL PROGRESS GROUP is currently not registered on the Peppol network.

What is the enterprise number of MEDICAL PROGRESS GROUP?

The enterprise number of MEDICAL PROGRESS GROUP is BE0447033408.

When was MEDICAL PROGRESS GROUP founded?

MEDICAL PROGRESS GROUP was founded on 27 March 1992.

Who are the directors of MEDICAL PROGRESS GROUP?

According to the 2025 annual accounts, the directors of MEDICAL PROGRESS GROUP are: Marc VAN GOSSUM.

Is MEDICAL PROGRESS GROUP a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 March 1992; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDICAL PROGRESS GROUP make in 2025?

MEDICAL PROGRESS GROUP posted a profit after taxes of € 88,033 in financial year 2025.

What is the revenue of MEDICAL PROGRESS GROUP?

As a small company, MEDICAL PROGRESS GROUP is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 142,242.

MEDICAL PROGRESS GROUP (Private Limited) - Brussel

Dossier MEDICAL PROGRESS GROUP, printed on 28 September 2026 from databakkes.be/en/0447033408/medical-progress-group. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MEDICAL PROGRESS GROUP from Brussel, company number BE0447033408, closed financial year 2025 with a result of € 88,033 after tax. For that financial year MEDICAL PROGRESS GROUP recorded a gross margin of € 142,242 and equity of € 324,388. Compared with financial year 2024, the result moved from € 75,473 to € 88,033. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 324,388

▲ 37% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 88,033

▲ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 18,119

▲ € 16,940 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 311,983.

People and assets in 2025

Vehicles and equipment

€ 8,389

▼ 47% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 34,556

▲ 167% vs 2024

€ 15,382 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1,928

▼ 93% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,300

▼ 10% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 132,531 Gross margin 2022: € 132,531 First fiscal year in the series	€ 139,192 Gross margin 2023: € 139,192 ▲ 5% vs 2022 (€ 132,531) Favourable step	€ 116,477 Gross margin 2024: € 116,477 ▼ 16% vs 2023 (€ 139,192) Unfavourable step	€ 142,242 Gross margin 2025: € 142,242 ▲ 22% vs 2024 (€ 116,477) Favourable step	▲ 22%
Profit after taxes	€ 72,406 Profit after taxes 2022: € 72,406 First fiscal year in the series	€ 83,578 Profit after taxes 2023: € 83,578 ▲ 15% vs 2022 (€ 72,406) Favourable step	€ 75,473 Profit after taxes 2024: € 75,473 ▼ 10% vs 2023 (€ 83,578) Unfavourable step	€ 88,033 Profit after taxes 2025: € 88,033 ▲ 17% vs 2024 (€ 75,473) Favourable step	▲ 17%
Equity	€ 77,304 Equity 2022: € 77,304 First fiscal year in the series	€ 160,882 Equity 2023: € 160,882 ▲ 108% vs 2022 (€ 77,304) Favourable step	€ 236,356 Equity 2024: € 236,356 ▲ 47% vs 2023 (€ 160,882) Favourable step	€ 324,388 Equity 2025: € 324,388 ▲ 37% vs 2024 (€ 236,356) Favourable step	▲ 37%
Total debts	€ 45,703 Total debts 2022: € 45,703 First fiscal year in the series	€ 41,219 Total debts 2023: € 41,219 ▼ 10% vs 2022 (€ 45,703) Favourable step	€ 44,669 Total debts 2024: € 44,669 ▲ 8% vs 2023 (€ 41,219) Unfavourable step	€ 41,784 Total debts 2025: € 41,784 ▼ 6% vs 2024 (€ 44,669) Favourable step	▼ 6%
Cash	€ 911 Cash 2022: € 911 First fiscal year in the series	€ 479 Cash 2023: € 479 ▼ 47% vs 2022 (€ 911) Unfavourable step	€ 1,178 Cash 2024: € 1,178 ▲ 146% vs 2023 (€ 479) Favourable step	€ 18,119 Cash 2025: € 18,119 ▲ € 16,940 vs 2024 (€ 1,178) Favourable step	▲ € 16,940
Land & buildings	€ 9,315 Land & buildings 2022: € 9,315 First fiscal year in the series	€ 6,990 Land & buildings 2023: € 6,990 ▼ 25% vs 2022 (€ 9,315) Unchanged	€ 4,610 Land & buildings 2024: € 4,610 ▼ 34% vs 2023 (€ 6,990) Unchanged	€ 34,211 Land & buildings 2025: € 34,211 ▲ € 29,602 vs 2024 (€ 4,610) Unchanged	▲ € 29,602
Retained profit	€ 64,899 Retained profit 2022: € 64,899 First fiscal year in the series	€ 148,477 Retained profit 2023: € 148,477 ▲ 129% vs 2022 (€ 64,899) Favourable step	€ 223,950 Retained profit 2024: € 223,950 ▲ 51% vs 2023 (€ 148,477) Favourable step	€ 311,983 Retained profit 2025: € 311,983 ▲ 39% vs 2024 (€ 223,950) Favourable step	▲ 39%
Dividend	€ 16,152 Dividend 2022: € 16,152 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 16,152) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 23,228 Bank debt 2022: € 23,228 First fiscal year in the series	€ 22,288 Bank debt 2023: € 22,288 ▼ 4% vs 2022 (€ 23,228) Favourable step	€ 12,921 Bank debt 2024: € 12,921 ▼ 42% vs 2023 (€ 22,288) Favourable step	€ 34,556 Bank debt 2025: € 34,556 ▲ 167% vs 2024 (€ 12,921) Unfavourable step	▲ 167%
Balance sheet total	€ 123,007 Balance sheet total 2022: € 123,007 First fiscal year in the series	€ 202,102 Balance sheet total 2023: € 202,102 ▲ 64% vs 2022 (€ 123,007) Unchanged	€ 281,025 Balance sheet total 2024: € 281,025 ▲ 39% vs 2023 (€ 202,102) Unchanged	€ 366,172 Balance sheet total 2025: € 366,172 ▲ 30% vs 2024 (€ 281,025) Unchanged	▲ 30%

Key figures of MEDICAL PROGRESS GROUP, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDICAL PROGRESS GROUP?

What happened at MEDICAL PROGRESS GROUP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 88,033 (▲ 17% vs 2024). filed late Source: NBB ↗
Mar 27, 1992 Start of the company according to the CBE. KBO

In short

From € 72,406 profit in 2022 to € 88,033 profit in 2025.

Paid € 132,253 in corporate taxes since 2022.

Best year ever: 2025, with € 88,033 profit.

Paid out € 16,152 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at MEDICAL PROGRESS GROUP? We notify you, reason included.

Follow MEDICAL PROGRESS GROUP

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Marc VAN GOSSUM

MEDICAL PROGRESS GROUP

Behind MEDICAL PROGRESS GROUP is Marc VAN GOSSUM.

See the full network in the app

Directors

According to the 2025 annual accounts

Marc VAN GOSSUM

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Gustave Demanetstraat 87

1020 Brussel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Fondation de Recherche en Pathologie digestive

COBRAMED

€ 12,361 gross margin · 2026

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0447.033.408
VAT number: BE 0447.033.408
Registered office: Gustave Demanetstraat 87, 1020 Brussel
Names & denominations: MEDICAL PROGRESS GROUP
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 March 1992
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗